Levels of
prostaglandin E(2) (
PGE(2)), a potent inhibitor of fibroblast function, are decreased in the lungs of patients with
pulmonary fibrosis, which has been shown to be because of limited expression of
cyclooxygenase-2 (COX-2). To further investigate the relative importance of COX-2 and
PGE(2) in the development of
fibrosis we have used a selective
COX-2 inhibitor and COX-2-deficient ((-/-) and (+/-)) mice in studies of
bleomycin-induced lung
fibrosis. We demonstrate in wild-type mice that
bleomycin-induced lung
PGE(2) production is predominantly COX-2 mediated. Furthermore, COX-2(+/-) mice show limited induction of
PGE(2) and an enhanced fibrotic response with increased lung
collagen content compared with wild-type mice after
bleomycin injury (P < 0.001). In contrast, COX-2(-/-) mice show increased levels of lung
PGE(2), compared with wild-type mice after injury (P < 0.05), because of compensatory up-regulation of COX-1, which appears to be associated with macrophage/monocytes but not fibroblasts derived from these mice. COX-2(-/-) mice show an enhanced and persistent inflammatory response to
bleomycin, however the fibrotic response to injury was unaltered compared with wild-type animals. These data provide further direct evidence for the importance of up-regulating COX-2 and
PGE(2) expression in protecting against the development of
fibrosis after
lung injury.